IP Library Granted Patent US 7,041,463
Granted Patent B2
US 7,041,463 · App. 10/237,563 · Granted May 9, 2006

Orthologues of human receptors and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,041,463
App. No.
10/237,563
Granted
May 9, 2006
Kind
B2
Abstract

Methods for identifying modulators of receptor activity using orthologues of human receptors are described. Additionally, a method for identifying an animal model useful in the screening of potential therapeutic agents is provided. The genes for bradykinin B 1 receptors from five mammalian species, vervet monkey, rhesus macaque, tree shrew, dog and pig, as well as the genes for CXCR2 receptors from chimpanzee, gorilla, orangutan, rhesus, vervet and baboon have been cloned and characterized and are described herein.

Claims (7)

1. A method of identifying a compound that modulates bradykinin B 1 receptor activity, comprising:

(a) contacting a test compound with a bradykinin B 1 receptor comprising an amino acid sequence chosen from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6; and

(b) measuring an effect of said compound on said receptor, wherein the effect to be measured is displacement of a ligand from the receptor, phosphatidyl inositol hydrolysis, release of intracellular Ca++, and arachidonic acid release.

2. The method of claim 1 , wherein the effect to be measured is displacement of a ligand from the receptor and wherein the ligand is chosen from des-Arg 10 -kallidin, des-Arg 10 Leu 9 -kallidin, des-Arg 9 -bradykinin, des-Arg 9 Leu 8 -bradykinin.

3. The method of claim 1 , wherein said bradykinin B 1 receptor is expressed by a recombinant host cell.

4. The method of claim 1 , wherein said test compound is a peptidic ligand.

5. The method of claim 1 , wherein said test compound is a non-peptidic ligand.

Assignments (6)
MERGER Recorded Jul 7, 2009
From: PHARMACOPEIA, INC.; LATOUR ACQUISITION, LLC
To: PHARMACOPEIA, LLC
Reel/Frame 022917/0419 →
CHANGE OF NAME Recorded Aug 17, 2007
From: PHARMACOPEIA DRUG DISCOVERY, INC.
To: PHARMACOPEIA, INC.
Reel/Frame 019704/0913 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DATE OF ROBERT HORLICK'S SIGNATURE PREVIOUSLY RECORDED ON REEL 016919 FRAME 0137. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTIVE ASSIGNMENT TO RE-RECORD ASSIGNMENT TO INCLUDE DATE OF ROBERT HORLICK'S SIGNATURE. Recorded Sep 7, 2006
From: HORLICK, ROBERT; ZHAO, JIUQUAO; SWANSON, ROBERT; WEBB, MARIA; STROHL, BARBARA; BALDWIN, JOHN J.; AULD, DOUGLAS S.
To: PHARMACOPEIA, INC.
Reel/Frame 018224/0258 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2005
From: PHARMACOPEIA, INC.
To: PHARMACOPEIA DRUG DISCOVERY, INC.
Reel/Frame 016918/0840 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2005
From: CHEN, XIAO GE
To: PHARMACOPEIA, INC.
Reel/Frame 016919/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2003
From: PHARMACOPEIA, INC.
To: PHARMACOPEIA DRUG DISCOVERY, INC.
Reel/Frame 013716/0074 →